Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...

ZimVie (ZIMV) announced the publication of a detailed scientific study demonstrating the surface texture of ZimVie’s premium implants may help ...

ZimVie (NASDAQ:ZIMV) may be worth $25-$29 a ... maker is weighing a potential sale amid acquisition interest. The company could be a target for strategic players or private equity firms, Needham ...

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and ...

Barclays lowered the firm’s price target on ZimVie (ZIMV) to $15 from $16 and keeps an Underweight rating on the shares. The firm says its 2025 medical technology outlook “hinges heavily” on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...